Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China's Government Investment, Policies Sustain IVD Market With High Double-digit Growth

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's in vitro diagnostics market was valued at $2 billion in 2009 and is expected to keep a steady pace of 18.5 percent compound annual growth rate in the next three to five years, according to global consulting company Frost & Sullivan

You may also be interested in...

China Is Raising Government Support For Biotech Industry In Next Five-year Plan

SHANGHAI - While China's National Development and Reform Commission is drafting its 12th five-year plan, government officials and its think tank recently disclosed that the biotech industry will be raised as a pillar industry and China is increasing its support to facilitate development of the industry

China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion

SHANGHAI - China issued its long-awaited three-year plan for its healthcare reform, and unveiled how the country will allocate RMB 850 billion ($124 billion) in the next three years

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts